<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Sandostatin</title><link>http://www.unboundmedicine.com/medline/ebm/research/Sandostatin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>The Effectiveness of the Treatment of Octreotide on Chylous Ascites After Liver Cirrhosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19051030/full_citation/The_Effectiveness_of_the_Treatment_of_Octreotide_on_Chylous_Ascites_After_Liver_Cirrhosis_</link><description>Zhou DX, Zhou HB, Wang Q, et al. <br/><span class="title">The Effectiveness of the Treatment of Octreotide on Chylous Ascites After Liver Cirrhosis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Digestive diseases and sciences">Dig Dis Sci 2008 Dec 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19051030/abstract/The_Effectiveness_of_the_Treatment_of_Octreotide_on_Chylous_Ascites_After_Liver_Cirrhosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19051030/full_citation/The_Effectiveness_of_the_Treatment_of_Octreotide_on_Chylous_Ascites_After_Liver_Cirrhosis_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19051030/The_Effectiveness_of_the_Treatment_of_Octreotide_on_Chylous_Ascites_After_Liver_Cirrhosis_">Find Related Articles</a> </description></item><item><title>Short bowel syndrome: searching for the proper diet.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19047836/full_citation/Short_bowel_syndrome:_searching_for_the_proper_diet_</link><description>Tilg H <br/><span class="title">Short bowel syndrome: searching for the proper diet. [Journal Article]</span><br/><span class="source" title="European journal of gastroenterology &amp; hepatology">Eur J Gastroenterol Hepatol 2008 Nov; 20(11):1061-3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19047836/abstract/Short_bowel_syndrome:_searching_for_the_proper_diet_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19047836/full_citation/Short_bowel_syndrome:_searching_for_the_proper_diet_">Full Citation</a></description></item><item><title>A Pilot Phase II Randomized, Cross-Over, Double-Blinded, Controlled Efficacy Study of Octreotide versus Hyoscine Hydrobromide for Control of Noisy Breathing at the End-of-Life.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19042837/full_citation/A_Pilot_Phase_II_Randomized_Cross_Over_Double_Blinded_Controlled_Efficacy_Study_of_Octreotide_versus_Hyoscine_Hydrobromide_for_Control_of_Noisy_Breathing_at_the_End_of_Life_</link><description>Clark K, Currow DC, Agar M, et al. <br/><span class="title">A Pilot Phase II Randomized, Cross-Over, Double-Blinded, Controlled Efficacy Study of Octreotide versus Hyoscine Hydrobromide for Control of Noisy Breathing at the End-of-Life. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of pain &amp; palliative care pharmacotherapy">J Pain Palliat Care Pharmacother 2008; 22(2):131-138.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19042837/abstract/A_Pilot_Phase_II_Randomized_Cross_Over_Double_Blinded_Controlled_Efficacy_Study_of_Octreotide_versus_Hyoscine_Hydrobromide_for_Control_of_Noisy_Breathing_at_the_End_of_Life_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19042837/full_citation/A_Pilot_Phase_II_Randomized_Cross_Over_Double_Blinded_Controlled_Efficacy_Study_of_Octreotide_versus_Hyoscine_Hydrobromide_for_Control_of_Noisy_Breathing_at_the_End_of_Life_">Full Citation</a></description></item><item><title>A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayers.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19041716/full_citation/A_combined_in_vitro_and_in_vivo_study_on_the_interactions_between_somatostatin_and_lipid_based_liquid_crystalline_drug_carriers_and_bilayers_</link><description>Cervin C, Vandoolaeghe P, Nistor C, et al. <br/><span class="title">A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayers. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences">Eur J Pharm Sci 2008 Nov 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19041716/abstract/A_combined_in_vitro_and_in_vivo_study_on_the_interactions_between_somatostatin_and_lipid_based_liquid_crystalline_drug_carriers_and_bilayers_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19041716/full_citation/A_combined_in_vitro_and_in_vivo_study_on_the_interactions_between_somatostatin_and_lipid_based_liquid_crystalline_drug_carriers_and_bilayers_">Full Citation</a></description></item><item><title>Well-differentiated endocrine carcinoma of the renal pelvis: Report of a case with sustained objective response to octreotide.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19041194/full_citation/Well_differentiated_endocrine_carcinoma_of_the_renal_pelvis:_Report_of_a_case_with_sustained_objective_response_to_octreotide_</link><description>Walter T, Mege-Lechevallier F, Scoazec JY, et al. <br/><span class="title">Well-differentiated endocrine carcinoma of the renal pelvis: Report of a case with sustained objective response to octreotide. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pathology, research and practice">Pathol Res Pract 2008 Nov 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19041194/abstract/Well_differentiated_endocrine_carcinoma_of_the_renal_pelvis:_Report_of_a_case_with_sustained_objective_response_to_octreotide_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19041194/full_citation/Well_differentiated_endocrine_carcinoma_of_the_renal_pelvis:_Report_of_a_case_with_sustained_objective_response_to_octreotide_">Full Citation</a></description></item><item><title>Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19040993/full_citation/Hepatic_artery_chemoinfusion_with_chemoembolization_for_neuroendocrine_cancer_with_progressive_hepatic_metastases_despite_octreotide_therapy_</link><description>Christante D, Pommier S, Givi B, et al. <br/><span class="title">Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. [Journal Article]</span><br/><span class="source" title="Surgery">Surgery 2008 Dec; 144(6):885-94.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19040993/abstract/Hepatic_artery_chemoinfusion_with_chemoembolization_for_neuroendocrine_cancer_with_progressive_hepatic_metastases_despite_octreotide_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19040993/full_citation/Hepatic_artery_chemoinfusion_with_chemoembolization_for_neuroendocrine_cancer_with_progressive_hepatic_metastases_despite_octreotide_therapy_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0039-6060(08)00583-7">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19040993/Hepatic_artery_chemoinfusion_with_chemoembolization_for_neuroendocrine_cancer_with_progressive_hepatic_metastases_despite_octreotide_therapy_">Find Related Articles</a> </description></item><item><title>(99m)Tc-HYNIC octreotide in neuroblastoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19039561/full_citation/_99m_Tc_HYNIC_octreotide_in_neuroblastoma_</link><description>Gambini JP, López Lerena JJ, Quagliata A, et al. <br/><span class="title">(99m)Tc-HYNIC octreotide in neuroblastoma. [Journal Article]</span><br/><span class="source" title="Annals of nuclear medicine">Ann Nucl Med 2008 Nov; 22(9):817-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19039561/abstract/_99m_Tc_HYNIC_octreotide_in_neuroblastoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19039561/full_citation/_99m_Tc_HYNIC_octreotide_in_neuroblastoma_">Full Citation</a></description></item><item><title>Micelles derivatized with octreotide as potential target-selective contrast agents in MRI.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19035577/full_citation/Micelles_derivatized_with_octreotide_as_potential_target_selective_contrast_agents_in_MRI_</link><description>Morisco A, Accardo A, Gianolio E, et al. <br/><span class="title">Micelles derivatized with octreotide as potential target-selective contrast agents in MRI. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of peptide science : an official publication of the European Peptide Society">J Pept Sci 2008 Nov 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19035577/abstract/Micelles_derivatized_with_octreotide_as_potential_target_selective_contrast_agents_in_MRI_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19035577/full_citation/Micelles_derivatized_with_octreotide_as_potential_target_selective_contrast_agents_in_MRI_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19035577/Micelles_derivatized_with_octreotide_as_potential_target_selective_contrast_agents_in_MRI_">Find Related Articles</a> </description></item><item><title>Control of allograft rejection in mice by applying a novel neuropeptide, cortistatin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19034397/full_citation/Control_of_allograft_rejection_in_mice_by_applying_a_novel_neuropeptide_cortistatin_</link><description>Wang J, Zhao R, Zhang F, et al. <br/><span class="title">Control of allograft rejection in mice by applying a novel neuropeptide, cortistatin. [JOURNAL ARTICLE]</span><br/><span class="source" title="Advances in therapy">Adv Ther 2008 Nov 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19034397/abstract/Control_of_allograft_rejection_in_mice_by_applying_a_novel_neuropeptide_cortistatin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19034397/full_citation/Control_of_allograft_rejection_in_mice_by_applying_a_novel_neuropeptide_cortistatin_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19034397/Control_of_allograft_rejection_in_mice_by_applying_a_novel_neuropeptide_cortistatin_">Find Related Articles</a> </description></item><item><title>Visceral Fat and Adiponectin: Associations with Insulin Resistance Are Tissue-Specific in Women.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19032037/full_citation/Visceral_Fat_and_Adiponectin:_Associations_with_Insulin_Resistance_Are_Tissue_Specific_in_Women_</link><description>Coker RH, Williams RH, Yeo SE, et al. <br/><span class="title">Visceral Fat and Adiponectin: Associations with Insulin Resistance Are Tissue-Specific in Women. [JOURNAL ARTICLE]</span><br/><span class="source" title="Metabolic syndrome and related disorders">Metab Syndr Relat Disord 2008 Nov 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19032037/abstract/Visceral_Fat_and_Adiponectin:_Associations_with_Insulin_Resistance_Are_Tissue_Specific_in_Women_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19032037/full_citation/Visceral_Fat_and_Adiponectin:_Associations_with_Insulin_Resistance_Are_Tissue_Specific_in_Women_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19032037/Visceral_Fat_and_Adiponectin:_Associations_with_Insulin_Resistance_Are_Tissue_Specific_in_Women_">Find Related Articles</a> </description></item></channel></rss>